Spermidine rejuvenates T lymphocytes and restores anticancer immunosurveillance in aged mice.
Francesca CastoldiGuido KroemerFederico PietrocolaPublished in: Oncoimmunology (2022)
Writing in Science, Al Habsi et al . show that spermidine boosts the efficacy of monoclonal antibodies targeting PD-L1 in aged tumor-bearing mice by enhancing fatty acid oxidation in CD8 T cells. These results open new therapeutic avenues to improve the effectiveness of anticancer immunotherapies in aged patients.